Evidence map›Paper›PMID 41272840›Full record

ArticleOrphanet journal of rare diseases2025

Upstream SOX9 deletion in a 46,XY girl with acampomelic campomelic dysplasia and absent minipuberty.

Anna Szoszkiewicz, Ewelina Bukowska-Olech, Paweł Kurzawa, Anna Sowińska-Seidler, Marek Niedziela, Zofia Kolesińska, Aleksander Jamsheer

Abstract readCase Reports
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna SzoszkiewiczDepartment of Medical Genetics, Doctoral School, Poznan University of Medical Sciences, Poznan, Poland. anszoszk@gmail.com.ORCID http://orcid.org/0000-0003-4848-9012
Ewelina Bukowska-OlechDepartment of Laboratory Diagnostics, Poznan University of Medical Sciences, Poznan, Poland.
Paweł KurzawaDepartment of Clinical Pathology and Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Anna Sowińska-SeidlerDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Marek NiedzielaDepartment of Pediatric Endocrinology and Rheumatology, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, Poland.
Zofia Kolesińska *Department of Pediatric Endocrinology and Rheumatology, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, Poland.
Aleksander Jamsheer *Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland. jamsheer@wp.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCampomelic dysplasia (CD) is a rare congenital skeletal dysplasia frequently associated with differences of sex development (DSD). In about 10% of affected individuals, the bowing of the long bones (campomelia) is absent, referred to as acampomelic campomelic dysplasia (ACD). Most patients with ACD carry heterozygous pathogenic variants within the SOX9 coding region or balanced chromosomal rearrangements involving the 17q24 region. A rarer mechanism involves deletions located upstream of the SOX9 gene. Only five ACD cases with upstream deletions of SOX9 have been reported in the medical literature.

resultsWe report a female patient affected by ACD with Pierre Robin sequence, complete gonadal dysgenesis (CGD), and hypotonia. Genetic testing revealed a de novo 1.671 Mb deletion located 191 kb upstream of the SOX9 gene. This chromosomal aberration represents the second-largest deletion upstream of SOX9 reported to date. In addition, we describe the patient's endocrine profile, which revealed an absent gonadotropin rise during minipuberty, followed by a delayed increase in infancy.

conclusionsThis study expands the clinical and molecular spectrum of ACD, enhancing our understanding of genotype-phenotype correlations of this condition. The phenotypic and endocrinological description of the proband may be helpful for clinicians who consult patients with DSD and skeletal dysplasia.

Indexed as

Campomelic DysplasiaSOX9 Transcription FactorFemaleGonadal Dysgenesis, 46,XYHumansSOX9 protein, humanSOX9 Transcription Factor17q24 deletionCampomelic dysplasiaMinipubertyPosition effectScoliosisSOX9 regulatory element

Identifiers

PMID41272840
PMCPMC12874664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.